APR 02, 2012 08:00 AM PDT

D-dimer in the Management of Venous Thromboembolism

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Professor Department of Medicine, Adjunct Professor Department of Radiological Sciences, College of Medicine University of Oklahoma Health Sciences Center
    Biography
      Suman Rathbun, MD is currently Director of the Vascular Medicine Program at OUHSC as well as director of the vascular laboratories and vascular fellowship at OU Medical Center, Oklahoma City, Oklahoma. Dr. Rathbun has been principal investigator in several research projects regarding pulmonary embolism and deep-vein thrombosis. Dr. Rathbun has published and presented both locally and nationally. She participated on the U.S. Surgeon General's task force for awareness of deep-vein thrombosis in Washington, DC. Currently, she serves as secretary to the Society of Vascular Medicine and chair of the education committee for the Venous Disease Coalition. Suman Rathbun received her doctorate of medicine at the University of Texas at San Antonio, Texas in 1994. Dr. Rathbun received her master's degree in epidemiology at the University of Oklahoma Health Sciences Center in 2004. She is board certified in internal medicine and vascular medicine.

    Abstract:

    Venous thromboembolism (VTE) is a serious prothrombotic disease state caused by acquired or inherited factors and is responsible for a high rate of morbidity and mortality.  Deep venous thrombosis (DVT) and pulmonary embolism (PE) refer to VTE located in the deep veins or lungs, respectively.  Diagnostic strategies for identification of VTE, DVT, and PE include imaging as well as laboratory testing methodologies such as the D-dimer assay.  The purpose of this educational activity is to review clinical decision rules, case studies, and the role of the D-dimer assay in the diagnostic management of VTE.

    • Recognize venous thromboembolism: deep-vein thrombosis and pulmonary embolism and its consequences.
    • Discuss the use of D-dimer in the exclusion of patients with clinically suspected first-episode or recurrent deep-vein thrombosis.
    • Discuss the utility of D-dimer in the determination of length of anticoagulation after first-episode deep-vein thrombosis.

    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    FEB 19, 2020 11:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    JUL 31, 2019 09:00 AM PDT
    C.E. CREDITS
    JUL 31, 2019 09:00 AM PDT
    DATE: July 31, 2019TIME: 9:00am PT, 12:00pm ET The choroid plexus, which makes up the blood-cerebrospinal fluid barrier in the central nervous system (CNS), lines the ventricle...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    AUG 15, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 15, 2019 09:00 AM PDT
    DATE: August 15, 2019TIME: 9:00am PDT, 12:00pm EDT Radiation therapy is a critical tool for the treatment of brain tumors, however, exposure to high doses of ionizing radiation...
    Loading Comments...
    Show Resources